Association of adverse outcomes of intrahepatic cholestasis of pregnancy with zonulin levels

Basit Öğe Kaydı
dc.contributor.authorDeniz, Cigdem Damla
dc.contributor.authorOzler, Sibel
dc.contributor.authorSayin, Fatma Kubra
dc.date.accessioned2024-02-23T14:17:13Z
dc.date.available2024-02-23T14:17:13Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractOur aim was to investigate serum zonulin levels in intrahepatic cholestasis of pregnancy (ICP) and to determine the usefulness of zonulin in ICP follow-up. A prospective case-control study was carried out which included 88 pregnant women (44 patients with ICP and 44 controls). Maternal serum samples obtained from all participants and zonulin levels were determined by enzyme-linked immunosorbent assay (ELISA). Compared with controls, women with ICP had significantly higher zonulin levels (mean 0.728 +/- 0.520 ng/mL vs. 1.303 +/- 0.63 ng/mL, p 001). According to the receiver operating characteristic (ROC) analysis performed for the predictive value of zonulin levels for ICP, the area under the curve (AUC) was 0.761 (95% CI: 0.661-0.860). Multivariable logistic regression analysis revealed serum zonulin levels was independently associated with adverse perinatal outcomes (OR = 1.278, 95% CI: 0.232-7.041), severity ICP (OR: 7.535, 95% CI: 1.597-13.553) and also unresponsiveness to treatment in ICP (OR: 4.178, 95% CI: 0.929-8.784). IMPACT STATEMENT What is already known on this subject? Zonulin is a regulator protein that increases the intestinal permeability by modulating the intercellular tight junctions (TJ). It is the only physiological protein known to control intestinal permeability and damage of the intestinal barrier is one of the causes of absorption disorders, inflammation and autoimmunity. ICP is a relatively non-threatening condition to women but is linked with a higher risk of preterm delivery, foetal distress and foetal death. What do the results of this study add? This study showed that increased levels of zonulin are associated with adverse perinatal outcomes, severity of ICP and unresponsiveness to treatment in ICP. What are the implications of these findings for clinical practice and/or further research? Focussing on preservation of intestinal permeability may be an alternative preventive strategy to reduce the adverse perinatal outcomes and severity of ICP. Further longitudinal studies are needed to verify the relationships among zonulin levels and pregnancy-related diseases.en_US
dc.description.sponsorshipKonya Education and Research Hospital, Konya, Turkeyen_US
dc.description.sponsorshipThis work was financially supported by Konya Education and Research Hospital, Konya, Turkey.en_US
dc.identifier.doi10.1080/01443615.2020.1820463
dc.identifier.endpage909en_US
dc.identifier.issn0144-3615
dc.identifier.issn1364-6893
dc.identifier.issue6en_US
dc.identifier.pmid33228404en_US
dc.identifier.scopus2-s2.0-85096514627en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage904en_US
dc.identifier.urihttps://doi.org/10.1080/01443615.2020.1820463
dc.identifier.urihttps://hdl.handle.net/20.500.12452/12996
dc.identifier.volume41en_US
dc.identifier.wosWOS:000591825300001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.ispartofJournal Of Obstetrics And Gynaecologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectZonulinen_US
dc.subjectCholestasisen_US
dc.subjectAdverse Pregnancy Outcomesen_US
dc.subjectIncreased Bile Acidsen_US
dc.subjectIntestinal Permeabilityen_US
dc.titleAssociation of adverse outcomes of intrahepatic cholestasis of pregnancy with zonulin levelsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu